The role of the efflux mechanisms in multidrug resistance in Mycobacterium tuberculosis

Medicine & Life Sciences

• Multiple Drug Resistance 100%
• Mycobacterium tuberculosis 93%
• Tuberculosis 78%
• Isoniazid 59%
• Ethidium 55%
• Mycobacterium smegmatis 53%
• Rifampin 30%
• Pharmaceutical Preparations 29%
• Escherichia coli 26%
• Physiological Adaptation 24%
• Capreomycin 23%
• Anti-Bacterial Agents 21%
• Extensively Drug-Resistant Tuberculosis 21%
• Mycobacterium 20%
• Tetracycline 20%
• Mycobacterium avium 19%
• Biological Models 19%
• Mutation 18%
• Kanamycin 18%
• Drug Resistance 17%
• Multidrug-Resistant Tuberculosis 17%
• Amikacin 16%
• Fluoroquinolones 16%
• Mycobacterium avium Complex 12%
• Macrolides 10%
• Public Health 10%
• Genes 9%
• Injections 8%
• Therapeutics 7%
• Thioridazine 6%
• Porins 6%
• Clarithromycin 5%
• Chlorpromazine 5%
• Protein Folding 5%
• Erythromycin 5%
• Verapamil 5%
• Microbial Sensitivity Tests 5%
• Permeability 4%
• Theoretical Models 3%
• Kinetics 3%

Chemistry

• Resistance 59%
• Pump 57%
• Ethidium Bromide 33%
• Tuberculostatic Agent 32%
• Rifampicin 32%
• Drug 25%
• Mutation 23%
• Capreomycin 22%
• Antimicrobial Agent 22%
• Amikacin 18%
• Tetracycline 18%
• Kanamycin 16%
• Strain 13%
• Ethidium 10%
• Macrolide Antibiotic Agent 9%
• Thioridazine 6%
• Clarithromycin 6%
• Verapamil 5%
• Chlorpromazine 5%
• Minimum Inhibitory Concentration 4%
• Protein Folding 4%
• Application 3%
• Permeability 3%